Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

8.640 -0.080 (-0.92%)
Official Closing Price Updated: 7:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,907,421
Open 8.670
Bid (Size) 8.520 (2)
Ask (Size) 9.150 (1)
Prev. Close 8.720
Today's Range 8.595 - 8.770
52wk Range 5.650 - 12.34
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
1 Healthcare Stock to Buy Hand Over Fist Going Into 2024
Hims & Hers Health is growing at an unprecedented rate. 
Via The Motley Fool
Ozempic vs. Mounjaro:: Battle of the bulge
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage 
Via MarketBeat
Exposures Product Safety

Performance

YTD
+36.71%
+36.71%
1 Month
+23.08%
+23.08%
3 Month
+32.31%
+32.31%
6 Month
-1.82%
-1.82%
1 Year
+19.17%
+19.17%

More News

Read More
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
From Hims & Hers Health, Inc.
Via Business Wire
This Growth Stock Could 10x in 10 Years
Via The Motley Fool
Hims & Hers earnings highlight expanded personalized treatments
Via MarketBeat
It Is Time To Buy Hims & Hers Stock
Via Talk Markets
Is Hims & Hers Stock a Buy Now?
Via The Motley Fool
5 Telehealth Stocks That Have Nothing But Upside
Via InvestorPlace
My Take: 4 Strong Growth Stocks to Buy This Week
Via The Motley Fool
2 No-Brainer Stocks to Buy Right Now for Less Than $50
Via The Motley Fool
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth
Via InvestorPlace
Top 5 Health Care Stocks That May Collapse In November
Via Benzinga
Earnings Scheduled For November 6, 2023
Via Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Is Hims & Hers Health Stock a Buy After Strong Earnings?
Via The Motley Fool
MSP Recovery, Uber, Hims & Hers Health, Celsius, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Hims & Hers Health Q3 Results Mixed But FY23 Revenue Guidance Raised, $50 Million Share Buyback
Via Benzinga
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
From Hims & Hers Health, Inc.
Via Business Wire
5 Companies Worth Watching Closely This Earnings Week
Via The Motley Fool
Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services
From Hims & Hers Health, Inc.
Via Business Wire
Where Will Hims & Hers Health Be in 5 Years?
Via The Motley Fool
Hims & Hers Names Khobi Brooklyn As Chief Communications Officer
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023
From Hims & Hers Health, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.